全文获取类型
收费全文 | 75018篇 |
免费 | 4215篇 |
国内免费 | 116篇 |
专业分类
耳鼻咽喉 | 1033篇 |
儿科学 | 2139篇 |
妇产科学 | 1535篇 |
基础医学 | 11391篇 |
口腔科学 | 2589篇 |
临床医学 | 6846篇 |
内科学 | 13620篇 |
皮肤病学 | 1753篇 |
神经病学 | 8113篇 |
特种医学 | 3965篇 |
外国民族医学 | 22篇 |
外科学 | 10501篇 |
综合类 | 274篇 |
一般理论 | 33篇 |
预防医学 | 4532篇 |
眼科学 | 1530篇 |
药学 | 5172篇 |
中国医学 | 124篇 |
肿瘤学 | 4177篇 |
出版年
2023年 | 383篇 |
2022年 | 342篇 |
2021年 | 744篇 |
2020年 | 756篇 |
2019年 | 835篇 |
2018年 | 1565篇 |
2017年 | 1324篇 |
2016年 | 1734篇 |
2015年 | 1544篇 |
2014年 | 1791篇 |
2013年 | 3041篇 |
2012年 | 4014篇 |
2011年 | 4464篇 |
2010年 | 2461篇 |
2009年 | 1817篇 |
2008年 | 4428篇 |
2007年 | 4644篇 |
2006年 | 4449篇 |
2005年 | 4364篇 |
2004年 | 4137篇 |
2003年 | 4162篇 |
2002年 | 4087篇 |
2001年 | 2909篇 |
2000年 | 3622篇 |
1999年 | 2095篇 |
1998年 | 791篇 |
1997年 | 664篇 |
1996年 | 528篇 |
1995年 | 440篇 |
1994年 | 460篇 |
1993年 | 403篇 |
1992年 | 452篇 |
1991年 | 415篇 |
1990年 | 376篇 |
1989年 | 431篇 |
1988年 | 357篇 |
1987年 | 347篇 |
1986年 | 334篇 |
1985年 | 389篇 |
1984年 | 419篇 |
1983年 | 349篇 |
1982年 | 323篇 |
1981年 | 286篇 |
1980年 | 262篇 |
1979年 | 340篇 |
1978年 | 248篇 |
1977年 | 257篇 |
1976年 | 248篇 |
1975年 | 252篇 |
1973年 | 226篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
91.
Flumazenil exerts intrinsic activity on sleep EEG and nocturnal hormone secretion in normal controls
A. Steiger J. Guldner C. J. Lauer C. Meschenmoser T. Pollmächer F. Holsboer 《Psychopharmacology》1994,113(3-4):334-338
The physiological function of benzodiazepine (BDZ) receptors includes regulation of sleep and neuroendocrine activity. Most of the pharmacological effects of BDZ are blocked by flumazenil. However, recent neurological and behavioral studies suggest that flumazenil has its own central intrinsic activity. This issue was addressed in a study of the sleep EEG and the nocturnal secretion of growth hormone and cortisol in ten normal male controls, who were given flumazenil either alone or in combination with the BDZ agonist midazolam, placebo and midazolam alone. Flumazenil prompted an increase in sleep onset latency, a decrease in slow wave sleep and an increase in wakefulness. Plasma cortisol concentrations after flumazenil administration were lower than after midazolam. Both flumazenil and midazolam decreased nocturnal growth hormone secretion. After simultaneous application of both BDZ receptor ligands the growth hormone blunting was amplified. Our study demonstrates that at the level of the sleep EEG and neuroendocrine activity flumazenil is capable of exerting both agonistic and inverse agonistic or antagonistic effects.Parts of this study were presented at the 69th Meeting of the Deutsche Physiologische Gesellschaft, Freiburg, 6–8 March, 1991 相似文献
92.
93.
Peritoneal morphology in children treated by continuous ambulatory peritoneal dialysis 总被引:2,自引:0,他引:2
Fritz Schneble Klaus-Eugen Bonzel Rüdiger Waldherr Sebastian Bachmann Helga Roth Karl Schärer 《Pediatric nephrology (Berlin, Germany)》1992,6(6):542-546
Fifty peritoneal biopsies (PB) from 35 patients with end-stage renal disease, treated by continuous ambulatory peritoneal dialysis (CAPD) and aged 2 months to 18 years, were examined by light microscopy (n=50) and/or scanning electron microscopy. PB were performed during surgical procedures immediately before the start of, during, or after the cessation of CAPD treatment. PB from 15 children without renal disease undergoing laparatomy were examined similarly. Before the start of CAPD, a scarcity and shortening of the mesothelial microvilli was observed by scanning electron microscopy. During and after CAPD, variable alterations of mesothelium, interstitium and capillaries were found. The mesothelial layer was absent in all 5 PB obtained during episodes of active peritonitis. In patients treated by CAPD for longer than 6 months, mesothelial denudation was observed more frequently (6/11) than in children treated for shorter periods (1/7) (P<0.08). Fibrosis of the peritoneal membrane was present in about 50% of patients during or after the cessation of CAPD without impairment of peritoneal function. No correlation was found between the presence of fibrosis and the frequency of peritonitis or the duration of CAPD treatment. 相似文献
94.
P. Rokkanen O. Böstman E. Hirvensalo E. A. Mäkelä E. Partio H. Pätiälä S. Vainionpää K. Vihtonen P. Törmälä 《European journal of orthopaedic surgery & traumatology : orthopedie traumatologie》1992,2(2):107-110
Résumé L'utilisation de matériaux d'ostéosynthèse biodégradables a l'avantage d'éviter la réintervention pour extraire le matériel. Les biomatériaux de polymères polyglycolides ont été expérimentés sur plus de 3 600 animaux de laboratoire avant leur introduction en pratique clinique. Depuis 1984 nous les avons utilisés comme matériau d'ostéosynthèse dans près de 1 700 cas parmi lesquels 880 cas de fracture malléolaire, 226 cas d'ostéotomie en chevron pour hallux valgus, 65 cas de fracture de la tête radiale et 54 cas de fracture de l'olécrane. Parmi les 800 premiers cas traités par broches biodégradables nous avons obtenu des résultats favorables et sans incidents dans 91 pour cent des cas. Il y eut 7 cas de fixation défaillante nécessitant une réintervention. Il y a eu 7 cas d'infection superficielle et 3 cas d'infection profonde. Nous avons observé la formation d'une collection séreuse sous-cutanée sans influence sur le résultat radiologique ou clinique dans 52 cas (6,5 %). Au vue de ces résultats et compte tenu des avantages économiques et psychologiques des matériaux biodégradables (pas de réintervention), on peut penser que l'usage de biomatériaux rivalise favorablement avec l'usage de matériaux conventionnels dans certains types d'ostéosynthèse.
Utilization of biodegradable implants in the surgical treatment of fractures and osteotomies
Summary The utilization of biodegradable implants instead of metals in orthopaedic surgery abolishes the need to remove the fixation material. For this study biodegradable rods and screws of self-reinforced polyglycolide, polylactide and lactide-glycolide copolymer were developed and manufactured. The clinical introduction of these implants was preceded by thorough experimental studies with 3 600 animals. From November 1984 the developed biodegradable method of osteofixation was used in 1 700 operations. These included 880 displaced malleolar fractures, 226 chevron-osteotomy for hallux valgus, 65 displaced fracture of the radial head, 54 displaced frature of the olecranon and other fresh fractures or orthopaedic operations. In the first 800 cases operated on using self-reinforced polyglycolide rods the postoperative course was uneventful (91%). Because of failure in the fixation reoperation was needed in 7 cases. A superficial wound infection was observed in 7 cases, deep infection in 3 and transient fluid accumulation in 52 cases (6,5%). Fluid accumulation did not influence the radiological or clinical end-result. The advantages of biodegradable fixation are many-sided. There is a costbenefit and clinical capacity is free for other use, and psychological advantages must be emphasised because removal of implants is not needed. The over all results of this study were considered favourable.相似文献
95.
96.
97.
98.
Tarja A. Soininvaara Hannu J.A. Miettinen Jukka S. Jurvelin Esko M. Alhava Heikki P.J. Kröger 《Journal of clinical densitometry》2004,7(4):424-431
Osteoarthrosis (OA) is often associated with pain and disability, which are relieved after total knee arthroplasty (TKA), but the nature of bone changes associated with OA is controversial. We examined preoperative hip and contralateral knee bone mineral density (BMD) in patients requiring TKA and monitored the BMD changes postoperatively. Sixty-nine patients, scheduled to have TKA for osteoarthrotic knees, had both hips and contralateral knee BMD measured by dual-energy X-ray absorptiometry (DXA) at the time of operation (baseline) and at 1 yr after operation. X-rays of the knee joints were also taken to evaluate the severity of OA. Preoperatively, 27% and 38% of the patients had total hip BMD Z-score more than 1 SD in the operated side and contralateral hips, respectively. In all regions of interest (ROI), the mean baseline BMD of the affected side proximal femur was significantly lower than that of the contralateral side (p < 0.0005-0.019). The severity of OA was not associated with BMD. During 1-yr follow-up, the postoperative knee status and the physical activity of the patients (AKS score) improved. However, neither the hip nor the nonoperated knee BMDs increased. Knee OA is associated with significantly lower BMD values in the affected side compared with the contralateral hip, and these levels remained similar or decreased during a 1-yr follow-up. We conclude that improved mobility after TKA does not improve the effects of preoperative disuse-associated bone loss in the short term. 相似文献
99.
Detection of microemboli in the subclavian vein of patients undergoing haemodialysis and haemodiafiltration using pulsed Doppler ultrasound. 总被引:1,自引:1,他引:0
Dirk W Droste Karsten Kühne Roland M Schaefer E Bernd Ringelstein 《Nephrology, dialysis, transplantation》2002,17(3):462-466
BACKGROUND: The pathophysiology leading to pulmonary side effects during haemodialysis and haemodiafiltration is not yet fully understood. Chronic microembolization, which can be demonstrated by pulsed Doppler ultrasound, may be one cause. METHODS: The study cohort consisted of 24 long-term dialysis patients undergoing haemodialysis (n=21) and online-haemodiafiltration (n=3), respectively. The subclavian vein downstream to the venous access was investigated during different phases of the procedure using a 2-MHz pulsed ultrasound device. RESULTS: In all periods investigated (connection, dialysis, disconnection), numerous microembolic signals (MES) were found in the subclavian vein. The numbers of MES detected during haemodiafiltration (314-709 MES per 10 min) were higher than during haemodialysis (0-81 MES per 10 min). CONCLUSIONS: The composition (gaseous or solid) and origin (pump, tubing system or shunt) of the microemboli detected remains unclear. Chronic microembolization may be one cause of pulmonary complications of haemodialysis and haemodiafiltration. The detection method described in this article will help us to better understand this process and to determine what role microemboli might play in pulmonary and central nervous system disorders. It may also help to optimize the devices and techniques used. 相似文献
100.
Starting from 4,4'-diamino-diphenylsulfone (DDS) as a lead structure, new 2-substituted analogues as well as new 2-substituted 4-alkylamino-4'-amino diphenylsulfones have been designed and synthetized in different ways. This has led to compounds the inhibitory activity of which against 7,8-dihydropteroic acid synthase of plasmodia and mycobacteria is clearly superior to that of sulfadoxine and in most cases to that of DDS. Of special interest is 4'-amino-4-n-propylamino-2-methyl-diphenylsulfone. Together with inhibitors of 7,8-dihydrofolate reductase in vitro and in vivo it possesses a marked synergistic inhibitory activity against plasmodia. In contrast to DDS in doses up to 200 mg/kg p.o. (cat) no methemoglobin formation is observed. The compound has been selected for further studies. 相似文献